FDA.reportPublic FDA data

NINLARO 2.3 MG Oral Capsule

RxCUI
1723763
RxNorm name
NINLARO 2.3 MG Oral Capsule
Display name
NINLARO 2.3 MG Oral Capsule
Full name
NINLARO 2.3 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NINLAROIXAZOMIBTakeda Pharmaceuticals America, Inc.038f2461-834b-4488-9ebd-863c83eef5a72026-08-11Warnings, Adverse reactionsExact identifier
rxcui: 1723763

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
038f2461-834b-4488-9ebd-863c83eef5a7NINLARO 2.3 MG Oral Capsule [PSN] · ixazomib 2.3 MG Oral Capsule [Ninlaro] [SBD] · Ninlaro 2.3 MG (as ixazomib citrate 3.3 MG) Oral Capsule [SY] · Ninlaro 2.3 MG Oral Capsule [SY]416These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 201520250818